Press Release: Noveome : Noveome Biotherapeutics Announces Issuance of U.S. Patent No. 12,121,546 "Treatment of Systemic Inflammatory Responses"
"This patent underscores our ongoing efforts to push the boundaries of innovation" stated Patrick Welch, CEO PITTSBURGH, PA, UNITED STATES, November 20, 2024 /EINPresswire.com/ -- Noveome Biotherapeutics, Inc., is a clinical stage Pittsburgh- ...
Read full article »
Noveome is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory and neurological disorders.
Read more